Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestineAlex Sparreboom, Olaf van Tellingen, Ulrich Mayer et al.|Proceedings of the National Academy of Sciences|1997Cited by 884
Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833Judith van Asperen, Jos H. Beijnen, Alex Sparreboom et al.|British Journal of Cancer|1997Cited by 203
Altered Pharmacokinetics of Vinblastine in Mdr1a P-glycoprotein-Deficient MiceJudith van Asperen, Olaf van Tellingen, W J Nooijen et al.|JNCI Journal of the National Cancer Institute|1996Cited by 177
Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoproteinJudith van Asperen, Jos H. Beijnen, Olaf van Tellingen et al.|British Journal of Cancer|1998Cited by 149
Enhanced oral absorption and decreased elimination of paclitaxel in mice cotreated with cyclosporin A.Judith van Asperen, Jos H. Beijnen, Olaf van Tellingen et al.|PubMed|1998Cited by 140